BALANCE SHEETS - USD ($)	Sep. 30, 2020	Sep. 30, 2019
Current Assets:
Cash and cash equivalents	$ 15,508,909	$ 8,444,774
Receivables	54,922	62,765
Prepaid expenses	1,313,432	524,953
Supplies used for R&D and manufacturing	820,052	782,363
Total current assets	17,697,315	9,814,855
Finance lease right of use assets	13,811,849	0
Operating lease right of use assets	1,198,958	0
Property and equipment, net	5,843,993	15,825,636
Patent costs, net	313,422	311,586
Deposits	1,670,917	1,670,917
Total assets	40,536,454	27,622,994
Current Liabilities:
Accounts payable	2,023,067	1,586,478
Accrued expenses	510,515	34,432
Due to employees	448,022	709,442
Derivative instruments, current portion	213,787	674,442
Lease liabilities, current portion	1,070,123	0
Other current liabilities	0	14,956
Total current liabilities	4,265,514	3,019,750
Derivative instruments, net of current portion	3,551,826	5,813,868
Finance lease liabilities, net of current portion	11,753,100	13,508,156
Operating lease liabilities, net of current portion	1,114,340	0
Other liabilities	125,000	147,553
Total liabilities	20,809,780	22,489,327
STOCKHOLDERS' EQUITY
Preferred stock, $.01 par value- 200,000 shares authorized; -0- shares issued and outstanding	0	0
Common stock, $.01 par value - 600,000,000 shares authorized; 38,730,150 and 35,231,776 shares issued and outstanding at September 30, 2020 and 2019, respectively	387,302	352,318
Additional paid-in capital	401,174,675	358,507,603
Accumulated deficit	(381,835,303)	(353,726,254)
Total stockholders' equity	19,726,674	5,133,667
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 40,536,454	$ 27,622,994